|
1
|
Fedor Z, Szentkirályi-Tóth A, Nagy G, Szimrók Z, Varga E, Pászti A, Pászti Z, Jerzsele Á, Pilgram O, Steinmetzer T, Mátis G, Neogrády Z, Pászti-Gere E. Interspecies Comparisons of the Effects of Potential Antiviral 3-Amidinophenylalanine Derivatives on Cytochrome P450 1A2 Isoenzyme. Vet Sci 2022; 9:vetsci9040156. [PMID: 35448654 PMCID: PMC9027957 DOI: 10.3390/vetsci9040156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 03/18/2022] [Accepted: 03/21/2022] [Indexed: 02/05/2023] Open
Abstract
In vitro models of animals vulnerable to SARS-CoV-2 infection can support the characterization of effective antiviral drugs, such as synthetic inhibitors of the transmembrane protease serine 2 (TMPRSS2). Changes in cytochrome P450 (CYP) 1A2 activities in the presence of the potential TMPRSS2/matriptase inhibitors (MI) were measured using fluorometric and luminescent assays. Furthermore, the cytotoxicity of these inhibitors was evaluated using the MTS method. In addition, 60 min-long microsomal stability assays were performed using an UPLC-MS/MS procedure to elucidate depletion rates of the inhibitors. CYP1A2 was influenced significantly by MI-463 and MI-1900 in rat microsomes, by MI-432 and MI-482 in beagle microsomes, and by MI-432, MI-463, MI-482, and MI-1900 in cynomolgus monkey microsomes. The IC50 values in monkey microsomes were 1.30 ± 0.14 µM, 2.4 ± 1.4 µM, 0.21 ± 0.09 µM, and 1.1 ± 0.8 µM for inhibitors MI-432, MI-463, MI-482, and MI-1900, respectively. The depletion rates of the parent compounds were lower than 50%, independently of the investigated animal species. The host cell factor TMPRSS2 is of key importance for the cross-species spread of SARS-CoV-2. Studies of the in vitro biotransformation of TMPRSS2 inhibitors provide additional information for the development of new antiviral drugs.
Collapse
Affiliation(s)
- Zsófia Fedor
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Anna Szentkirályi-Tóth
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Gábor Nagy
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Zoltán Szimrók
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Eszter Varga
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Anna Pászti
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Zoltán Pászti
- Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, 1117 Budapest, Hungary;
| | - Ákos Jerzsele
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
| | - Oliver Pilgram
- Faculty of Pharmacy, Institute of Pharmaceutical Chemistry, Philipps University Marburg, 35037 Marburg, Germany; (O.P.); (T.S.)
| | - Torsten Steinmetzer
- Faculty of Pharmacy, Institute of Pharmaceutical Chemistry, Philipps University Marburg, 35037 Marburg, Germany; (O.P.); (T.S.)
| | - Gábor Mátis
- Division of Biochemistry, Department of Physiology and Biochemistry, University of Veterinary Medicine, 1078 Budapest, Hungary; (G.M.); (Z.N.)
| | - Zsuzsanna Neogrády
- Division of Biochemistry, Department of Physiology and Biochemistry, University of Veterinary Medicine, 1078 Budapest, Hungary; (G.M.); (Z.N.)
| | - Erzsébet Pászti-Gere
- Department of Pharmacology and Toxicology, University of Veterinary Medicine, 1078 Budapest, Hungary; (Z.F.); (A.S.-T.); (G.N.); (Z.S.); (E.V.); (A.P.); (Á.J.)
- Correspondence:
| |
Collapse
|